Advisory Board
The external advisory board for the Genetic Epidemiology Research Institute (GERI) convenes twice each year to encourage involvement between our members and to plan our activities and research collaborations.
The advisory board's areas of focus are:
- GERI strategic planning
- Membership
- Distinguished speaker series
- Symposia
- Shared resources
GERI's advisory board is structured to be representative of the region’s major hospitals, organized medicine, local health departments, institutions of higher learning (health and medicine), health planning agencies, community volunteer organizations that are devoted to cancer, as well as other cancer organizations.
Advisory board duties
The advisory board is expected to:
- Advise with respect to the use of data generated by the GERI researchers
- Advise with regard to evaluating measures designed to eliminate, alleviate or ameliorate cancer, and to respond to community concerns with regard to cancer risk
- Advise regarding setting priorities related to proposed research or analysis or routine reports using the regional registry data
- Advise regarding issues of confidentiality and appropriate use of abstracted patient data and follow-up
- Advise on fundraising for the Department of Epidemiology's Center for Cancer Genetics Research and Prevention and the recruitment of outstanding program scientists
- Advise on management of public queries on suspected cancer clusters
- Advise on enhancing community relations via cancer prevention and control education, and establishing strategic collaborative partnerships with other scientific and community-based organizations
- Advise on the institute's long-term scientific goals for meeting the challenges of cancer genetics, prevention and control
Administration
Administrative functions of the external advisory board are coordinated and managed by GERI's director, Hoda Anton-Culver, PhD, and GERI administrative officer Farah Toullier-Garcia.